Prevalence of Neurasthenia, Comorbidity, and Association with Impairment Among a Nationally Representative Sample of US Adults

Overview

Journal Soc Psychiatry Psychiatr Epidemiol

Specialties Psychiatry
Public Health
Social Sciences

Date 2012 Feb 22

PMID 22349152

Authors

Kristine M Molina

Chih-Nan Chen

Margarita Alegria

Huijun Li

Affiliations

Soon will be listed here.

Abstract

Purpose: There are no current psychiatric epidemiological studies examining prevalence estimates of neurasthenia across different racial and ethnic groups in the US. This study compares prevalence rates of International Classification of Diseases (ICD-10) lifetime and 12-month neurasthenia across racial/ethnic groups in the US (Asians, African Americans, Latinos, and non-Latino Whites) and by levels of acculturation. We examine comorbidity of neurasthenia with DSM-IV psychiatric disorders and the association between neurasthenia and impairment.

Methods: We used a pooled sample (N = 10, 118) from two nationally representative household surveys of adults ages 18 years and older: the National Comorbidity Survey-Replication (NCS-R) and the National Latino and Asian American Study (NLAAS).

Results: Among the total sample, the adjusted prevalence rates of lifetime and 12-month neurasthenia with exclusionary criteria were 2.22 and 1.19%. The adjusted prevalence rates for lifetime and 12-month neurasthenia without exclusionary criteria were 4.89 and 2.80%. There were significant racial/ethnic group differences in prevalence for both lifetime and past-year neurasthenia, with Asians reporting significantly lower prevalence of neurasthenia than their non-Latino White counterparts. Less acculturated individuals were at a decreased risk for lifetime and past-year neurasthenia. Lifetime neurasthenia was associated with increased odds of meeting lifetime criteria for any depressive, any anxiety, and any substance use disorder. Respondents with lifetime or past-year neurasthenia had significantly greater levels of impairment compared to those without neurasthenia.

Conclusion: Neurasthenia is a prevalent condition deserving further research attention given its comorbidity with other psychiatric disorders and its association with functional impairment.

References

Ajdacic-Gross V, Horvath S, Canjuga M, Gamma A, Angst J, Rossler W . How ubiquitous are physical and psychological complaints in young and middle adulthood? A longitudinal perspective. Soc Psychiatry Psychiatr Epidemiol. 2006; 41(11):881-8. DOI: 10.1007/s00127-006-0111-x. View

Pennell B, Bowers A, Carr D, Chardoul S, Cheung G, Dinkelmann K . The development and implementation of the National Comorbidity Survey Replication, the National Survey of American Life, and the National Latino and Asian American Survey. Int J Methods Psychiatr Res. 2005; 13(4):241-69. PMC: 6878451. DOI: 10.1002/mpr.180. View

Heun R, Muller H, Freyberger H, Maier W . Reliability of interview information in a family study in the elderly. Soc Psychiatry Psychiatr Epidemiol. 1998; 33(3):140-4. DOI: 10.1007/s001270050035. View

Kleinman A . Neurasthenia and depression: a study of somatization and culture in China. Cult Med Psychiatry. 1982; 6(2):117-90. DOI: 10.1007/BF00051427. View

Cao Y, Zhang Y, Chang D, Wang G, Zhang X . Psychosocial and immunological factors in neurasthenia. Psychosomatics. 2009; 50(1):24-9. DOI: 10.1176/appi.psy.50.1.24. View

Abbey S, Garfinkel P . Neurasthenia and chronic fatigue syndrome: the role of culture in the making of a diagnosis. Am J Psychiatry. 1991; 148(12):1638-46. DOI: 10.1176/ajp.148.12.1638. View

Alegria M . The challenge of acculturation measures: what are we missing? A commentary on Thomson & Hoffman-Goetz. Soc Sci Med. 2009; 69(7):996-8. PMC: 2743758. DOI: 10.1016/j.socscimed.2009.07.006. View

Jason L, Richman J, Rademaker A, Jordan K, Plioplys A, Taylor R . A community-based study of chronic fatigue syndrome. Arch Intern Med. 1999; 159(18):2129-37. DOI: 10.1001/archinte.159.18.2129. View

Kalibatseva Z, Leong F . Depression among Asian Americans: Review and Recommendations. Depress Res Treat. 2011; 2011:320902. PMC: 3180820. DOI: 10.1155/2011/320902. View

10.

Jason L, Corradi K, Torres-Harding S, Taylor R, King C . Chronic fatigue syndrome: the need for subtypes. Neuropsychol Rev. 2005; 15(1):29-58. DOI: 10.1007/s11065-005-3588-2. View

11.

Takeuchi D, Zane N, Hong S, Chae D, Gong F, Gee G . Immigration-related factors and mental disorders among Asian Americans. Am J Public Health. 2006; 97(1):84-90. PMC: 1716230. DOI: 10.2105/AJPH.2006.088401. View

12.

Hickie I, Davenport T, Issakidis C, Andrews G . Neurasthenia: prevalence, disability and health care characteristics in the Australian community. Br J Psychiatry. 2002; 181:56-61. DOI: 10.1192/bjp.181.1.56. View

13.

Harvey S, Wessely S, Kuh D, Hotopf M . The relationship between fatigue and psychiatric disorders: evidence for the concept of neurasthenia. J Psychosom Res. 2009; 66(5):445-54. PMC: 3500687. DOI: 10.1016/j.jpsychores.2008.12.007. View

14.

Chisolm T, Abrams H, McArdle R, Wilson R, Doyle P . The WHO-DAS II: psychometric properties in the measurement of functional health status in adults with acquired hearing loss. Trends Amplif. 2005; 9(3):111-26. PMC: 4111522. DOI: 10.1177/108471380500900303. View

15.

Hanel G, Henningsen P, Herzog W, Sauer N, Schaefert R, Szecsenyi J . Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study. J Psychosom Res. 2009; 67(3):189-97. DOI: 10.1016/j.jpsychores.2009.04.013. View

16.

Lee S, Yu H, Wing Y, Chan C, Lee A, Lee D . Psychiatric morbidity and illness experience of primary care patients with chronic fatigue in Hong Kong. Am J Psychiatry. 2000; 157(3):380-4. DOI: 10.1176/appi.ajp.157.3.380. View

17.

Schwartz P . Why is neurasthenia important in Asian cultures?. West J Med. 2002; 176(4):257-8. PMC: 1071745. View

18.

Kroenke K, Spitzer R, deGruy 3rd F, Hahn S, Linzer M, Williams J . Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry. 1997; 54(4):352-8. DOI: 10.1001/archpsyc.1997.01830160080011. View

19.

Lee S, Kleinman A . Are somatoform disorders changing with time? The case of neurasthenia in China. Psychosom Med. 2007; 69(9):846-9. DOI: 10.1097/PSY.0b013e31815b0092. View

20.

Alegria M, Mulvaney-Day N, Torres M, Polo A, Cao Z, Canino G . Prevalence of psychiatric disorders across Latino subgroups in the United States. Am J Public Health. 2006; 97(1):68-75. PMC: 1716243. DOI: 10.2105/AJPH.2006.087205. View